GN Store Nord EBITDA Margin 2016-2024 | GNNDY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for GN Store Nord (GNNDY) over the last 10 years. The current EBITDA margin for GN Store Nord as of December 31, 2024 is .
| GN Store Nord EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $2.61B | $0.47B | 18.02% |
| 2024-09-30 | $2.62B | $0.45B | 17.27% |
| 2024-06-30 | $2.66B | $0.44B | 16.44% |
| 2024-03-31 | $2.65B | $0.43B | 16.22% |
| 2023-12-31 | $2.63B | $0.38B | 14.37% |
| 2023-09-30 | $2.63B | $0.39B | 14.93% |
| 2023-06-30 | $2.62B | $0.38B | 14.59% |
| 2023-03-31 | $2.67B | $0.40B | 14.78% |
| 2022-12-31 | $2.65B | $0.37B | 14.13% |
| 2022-09-30 | $2.54B | $0.38B | 15.02% |
| 2022-06-30 | $2.51B | $0.42B | 16.62% |
| 2022-03-31 | $2.43B | $0.45B | 18.59% |
| 2021-12-31 | $2.51B | $0.57B | 22.71% |
| 2021-09-30 | $2.52B | $0.58B | 22.85% |
| 2021-06-30 | $2.51B | $0.62B | 24.57% |
| 2021-03-31 | $2.29B | $0.51B | 22.33% |
| 2020-12-31 | $2.06B | $0.43B | 20.78% |
| 2020-09-30 | $1.96B | $0.44B | 22.25% |
| 2020-06-30 | $1.82B | $0.37B | 20.39% |
| 2020-03-31 | $1.89B | $0.44B | 23.49% |
| 2019-12-31 | $1.88B | $0.46B | 24.47% |
| 2019-09-30 | $1.85B | $0.44B | 24.01% |
| 2019-06-30 | $1.80B | $0.43B | 23.65% |
| 2019-03-31 | $1.75B | $0.41B | 23.52% |
| 2018-12-31 | $1.68B | $0.39B | 23.41% |
| 2018-09-30 | $1.59B | $0.37B | 22.97% |
| 2018-06-30 | $1.55B | $0.36B | 23.40% |
| 2018-03-31 | $1.50B | $0.35B | 23.08% |
| 2017-12-31 | $1.46B | $0.33B | 22.80% |
| 2017-09-30 | $1.35B | $0.33B | 24.28% |
| 2017-06-30 | $1.31B | $0.31B | 23.93% |
| 2017-03-31 | $1.30B | $0.31B | 24.00% |
| 2016-12-31 | $1.29B | $0.31B | 24.42% |
| 2016-09-30 | $1.30B | $0.54B | 41.75% |
| 2016-06-30 | $1.29B | $0.77B | 60.06% |
| 2016-03-31 | $1.25B | $1.00B | 80.34% |
| 2015-12-31 | $1.22B | $1.22B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.362B | $2.609B |
| GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company's operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells hands-free communications solutions in the form of headsets for mobile phones and traditional phones. GN ReSound segment operates within the hearing instrument industry, and produces and sells hearing healthcare instruments and related products. It offers hearing aids and accessories under the ReSound, Beltone and Interton brand names. GN Store Nord A/S is based in Ballerup, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |